Explore All Access
Check if your research matches the topics covered in NEOPLASIA?
- Degree of match
- Common matching concepts
- Additional journal recommendations
NEOPLASIA : Impact Factor & More
eISSN: 1476-5586pISSN: 1476-5586
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
NEOPLASIA Key Metrics
Impact Factor 
< 5
Time to Publish
View Chart Mo
Topics Covered on NEOPLASIA
Cancer
P53 pathway
Bone marrow
Lung cancer
Head and neck
Glioblastoma
DNA damage
Breast cancer
Tumor microenvironment
Drug delivery
Epidermal growth factor receptor
Extracellular vesicles
Cisplatin
Mathematical model
Neuroblastoma
Gene expression
Prostate cancer
Bystander effect
Overall survival
Hepatocellular carcinoma
NEOPLASIA Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months44%
4 to 6 months48%
7 to 9 months8%
Above 9 months0%
Did you find this useful?
Planning to publish in NEOPLASIA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in NEOPLASIA
Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia
- 26 Oct 2021
- Neoplasia
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation
- 21 Oct 2021
- Neoplasia
Retraction notice to <Recruitment of Tiam1 to Semaphorin 4D activates Rac and enhances proliferation, invasion and metastasis in oral squamous cell carcinoma> <[Neoplasia 19 (2016) 65-74]>
- 1 Aug 2021
- Neoplasia
Correction
- 1 Oct 2013
- Neoplasia
Correction
- 1 Oct 2013
- Neoplasia
Correction
- 1 Oct 2013
- Neoplasia
Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia
- 26 Oct 2021
- Neoplasia
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation
- 21 Oct 2021
- Neoplasia
Retraction notice to <Recruitment of Tiam1 to Semaphorin 4D activates Rac and enhances proliferation, invasion and metastasis in oral squamous cell carcinoma> <[Neoplasia 19 (2016) 65-74]>
- 1 Aug 2021
- Neoplasia
Correction
- 1 Oct 2013
- Neoplasia
Correction
- 1 Oct 2013
- Neoplasia
Correction
- 1 Oct 2013
- Neoplasia
FAQs on NEOPLASIA
How long has NEOPLASIA been actively publishing? 
NEOPLASIA has been in operation since 1999 till date.
What is the publishing frequency of NEOPLASIA?
NEOPLASIA published with a Monthly frequency.
How many articles did NEOPLASIA publish last year?
In 2023, NEOPLASIA publsihed undefined articles.
What is the eISSN & pISSN for NEOPLASIA?
For NEOPLASIA, eISSN is 1476-5586 and pISSN is 1476-5586.
Who is the publisher of NEOPLASIA?
ELSEVIER SCIENCE INC is the publisher of NEOPLASIA.